Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors

Authors

Eriko Katsuta, Roswell Park Comprehensive Cancer Center
Malgorzata Gil-Moore, Roswell Park Comprehensive Cancer Center
Justine Moore, Roswell Park Comprehensive Cancer Center
Mohamed Yousif, Roswell Park Comprehensive Cancer Center
Alex A Adjei, Mayo Clinic
Yi Ding, Roswell Park Comprehensive Cancer Center
Justin Caserta, Sumitomo Dainippon Pharma Oncology, Inc.
Carmen M Baldino, Walden Biosciences, Inc.
Kelvin P Lee, Roswell Park Comprehensive Cancer Center
Irwin H Gelman, Roswell Park Comprehensive Cancer Center
Kazuaki Takabe, Roswell Park Comprehensive Cancer Center
Mateusz Opyrchal, Washington University School of Medicine in St. Louis

Journal

International journal of oncology

Publication Date

10-1-2022

Volume

61

Issue

4

First Page

114

Document Type

Open Access Publication

DOI

10.3892/ijo.2022.5404

Rights and Permissions

Katsuta E, Gil-Moore M, Moore J, Yousif M, Adjei AA, Ding Y, Caserta J, Baldino CM, Lee KP, Gelman IH, Takabe K, Opyrchal M. Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors. Int J Oncol. 2022 Oct;61(4):114. doi: 10.3892/ijo.2022.5404. Copyright: © Katsuta et al. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License.

Recommended Citation

Katsuta, Eriko; Gil-Moore, Malgorzata; Moore, Justine; Yousif, Mohamed; Adjei, Alex A; Ding, Yi; Caserta, Justin; Baldino, Carmen M; Lee, Kelvin P; Gelman, Irwin H; Takabe, Kazuaki; and Opyrchal, Mateusz, "Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors." International journal of oncology. 61, 4. 114 (2022).
https://digitalcommons.wustl.edu/oa_4/32